We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SSNC:NASDAQSS&C Technologies Holdings, Inc. Analysis

Data as of 2026-05-26 - not real-time

$67.04

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

SS&C Technologies is trading at $67.04, comfortably above its 30‑day support of $64.51 but still well below the 200‑day SMA of $80.20, indicating a bearish technical backdrop. The stock’s RSI of 45 suggests neutral momentum, while the MACD line sits just above its signal, offering a hint of bullishness. Fundamentally, the company appears undervalued – its forward PE of 8.94 and a DCF‑derived fair value of $70.41 imply roughly a 5% intrinsic upside, and the price‑to‑earnings gap versus the industry average (20.8 vs 39.5) reinforces this view. Revenue is growing at 8.8% YoY, margins are solid (gross 48%, operating 24%), and free cash flow exceeds $1.27 bn, supporting a sustainable dividend yield of 1.61% with a modest 33% payout ratio. The recent $1.5 bn stock repurchase authorization adds a further catalyst, potentially tightening supply and boosting shareholder returns.
Given the blend of growth drivers, attractive valuation metrics, and a stable dividend, the medium‑ to long‑term outlook is positive, though short‑term price pressure may persist amid the broader bearish trend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support but below key moving averages
  • Neutral RSI and modest MACD bullish crossover
  • Upcoming stock repurchase may limit downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to peers and DCF fair value
  • Strong revenue growth and expanding free cash flow
  • Attractive forward PE and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust recurring software revenue across global markets
  • Continued cash generation supporting dividend and buybacks
  • Strategic positioning in financial‑services and healthcare software

Key Metrics & Analysis

Financial Health

Revenue Growth8.80%
Profit Margin12.65%
P/E Ratio20.8
ROE11.80%
ROA4.53%
Debt/Equity110.67
P/B Ratio2.3
Op. Cash Flow$1.8B
Free Cash Flow$1.3B
Industry P/E39.5

Technical Analysis

TrendBearish
RSI45.5
Support$64.51
Resistance$71.06
MA 20$67.77
MA 50$68.87
MA 200$80.20
MACDBullish
VolumeStable
Fear & Greed Index91.52

Valuation

Fair Value$70.41
Target Price$94.78
Upside/Downside41.37%
GradeUndervalued
TypeBlend
Dividend Yield1.61%

Risk Assessment

Beta0.74
Volatility26.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.